Verve Therapeutics How To Build A Gene Editing Biotech
Verve Therapeutics’ co-founder and CEO Sekar Kathiresan offers insight into how he launched a gene editing drug company and dosed the first...
Stay updated with breaking news from Ben Comer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Verve Therapeutics’ co-founder and CEO Sekar Kathiresan offers insight into how he launched a gene editing drug company and dosed the first...
In an exclusive interview, FDA’s Peter Marks discusses CBER priorities, PDUFA VII funding, and improving the dialogue between regulators and...
Additional executive responses to our 2023 manufacturing and supply chain outlook questions.
Additional experts weigh in on Life Science Leader's 2023 finance and funding outlook questions.
Biopharma executives offer options, tips and strategies for navigating finance and funding challenges in 2023.